Viking Therapeutics Trial Shows Promise for Less Frequent Maintenance Dosing

By Elaine Chen · STAT News · 2026-09-22

According to reporting from STAT News, Viking Therapeutics has released Phase 2 data indicating its injectable obesity candidate maintains efficacy even when patients switch to monthly or bi-monthly schedules. This shift away from the standard weekly injection model could signifi

According to reporting from STAT News, Viking Therapeutics has released Phase 2 data indicating its injectable obesity candidate maintains efficacy even when patients switch to monthly or bi-monthly schedules. This shift away from the standard weekly injection model could signifi